Search

everythinglearnresearchcommunity

for

Search:↓

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

Somatic BHD mutations are rare in Japanese renal tumors.

Three genes linked to the development of trichilemmal cysts were found.

Genetic testing is crucial for diagnosing congenital atrichia, a rare condition causing irreversible hair loss.

New mutations in the DSG4 gene cause a rare hair condition.

The research identified six functional hair keratin genes and four pseudogenes, providing insights into hair formation and gene organization.

Ancient DNA blocks are still present in human genomes, possibly due to advantages they provide.

A new genetic model may improve treatment and diagnosis for certain inherited skin diseases.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.